Treatments for COVID-19: Lessons from 2020 and new therapeutic options
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference104 articles.
1. A pneumonia outbreak associated with a new coronavirus of probable bat origin;Zhou;Nature,2020
2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2;Gorbalenya;Nat Microbiol,2020
3. Coronavirus biology and replication: implications for SARS-CoV-2;V’kovski;Nat Rev Microbiol,2021
4. The first 12 months of COVID-19: a timeline of immunological insights;Carvalho;Nat Rev Immunol,2021
5. COVID-19 vaccines: where we stand and challenges ahead;Forni;Cell Death Differ,2021
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Descriptions of Scientific Evidence and Uncertainty of Unproven COVID-19 Therapies in US News: Content Analysis Study;JMIR Infodemiology;2024-08-29
2. New methods for resolution of hydroxychloroquine by forming diastereomeric salt and adding chiral mobile phase agent on RP‐HPLC;Chirality;2024-05
3. Assessment of the efficiency of treatment of patients with COVID-19 (literature review);Medicni perspektivi;2024-04-01
4. Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: Systematic review and network meta-analysis;Antiviral Research;2024-01
5. Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation;European Journal of Physical and Rehabilitation Medicine;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3